NCT07631286

Ejaculatory-Sparing HoLEP vs Standard HoLEP

Recruiting
NAAges 18+InterventionalTreatment
Northwestern University
~48 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:Ejaculatory-sparing (ES-sparing) HoLEP

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of retrograde ejaculation
Measured over 1 year
+1 more outcome measured
Enlarged Prostate (BPH)
Enlarged Prostate With Lower Urinary Tract Symptoms
1 sites across 1 states
Illinois1
  • Amy E Krambeck, MD · PRINCIPAL_INVESTIGATOR · Northwestern University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

Patients with pre-existing retrograde ejaculation
Patients who are not sexually active
Patients with indwelling urinary catheter prior to surgery, neurological disease, or history of prior prostatic/urethral surgery that may impact ejaculation
Patients who lack decisional capacity
Patients unable to read/speak English
  • Incidence of retrograde ejaculation1 year

    Patient reported incidence of experiencing retrograde ejaculation

  • Ejaculatory satisfaction1 year

    Patient reported satisfaction of ejaculation using Male Sexual Health Questionnaire - Ejaculatory Dysfunction (MSHQ-EjD) questionnaire. The MSHQ-EjD-SF evaluates the following parameters in regards to ejaculation: Frequency, Force, Volume and Bother (How much are you bothered by any ejaculation difficulties) on a 6-point Likert scale (typically scored 0 to 5). Interpretation: Higher scores indicate better ejaculatory function, while lower scores denote dysfunction and a greater level of personal distress regarding one's ejaculatory function.